About
Chris Bradley is a biotech and health-tech entrepreneur best known as founder/CEO of Loki Therapeutics, an immuno-oncology company developing cancer therapeutics based on childhood-vaccination recall antigens. NYU Tandon lists him as Adjunct Faculty in Technology Management and Innovation, and longevity-sector profiles also identify him as CEO and co-founder of Matter Bio. Earlier profiles note he co-founded Mana Health, which was acquired by Comcast NBCUniversal in 2018.
Areas of interest
longevitybiotechimmuno-oncologygenetic interventionshealth ITmedical data interoperabilitytechnology managementcancer therapeutics